Einhorn on Tesla: ‘Like Lehman, We Think the Deception is About to Catch Up’ (CNBC)
Hedge fund manager David Einhorn is blasting Tesla again. “Like Lehman, we think the deception is about to catch up to TSLA,” Einhorn said in an investor letter Friday. The hedge fund manager’s bearish call on Lehman was one of the most prescient calls of the entire financial crisis nearly a decade ago. In May 2008, just a few months before Lehman Brothers declared bankruptcy, Einhorn said at the Ira W. Sohn Investment Research Conference that the investment bank was a risk to the financial system and questioned its accounting. He confirmed his firm Greenlight was short Lehman during that speech.
Michael Dell and Silver Lake in Showdown with Shareholders Over VMware Plan (CNBC)
A showdown is looming between Dell Technologies and the shareholders who own the tracking stock for its 81 percent stake in VMware. Amid widespread opposition to the plan for buying that tracking stock, Dell’s owners, Michael Dell and Silver Lake Partners, are considering other alternatives, including raising the price they are offering or dropping the plan altogether.
Ismagilov/shutterstock.com
Hedge Fund Managers Don’t Want To Be Hedge Fund Managers Anymore (DealBreaker)
Running a hedge fund certainly has its rewards; just ask David Tepper. But it’s also a tremendous pain in the ass, between the endless hours trying to find an edge and the whiny investor for whom it is never good enough. So eventually, the time comes when the hedge fund manager, to paraphrase Leon Cooperman, has wasted enough of his life in the endeavor. That time has come for Boston-based Highfields Capital Management’s Jonathon Jacobson, and without so much as a scratch on a valet’s face.
Brazil Hedge-Fund Icon Sees Bolsonaro as Favorite to Win Vote (Bloomberg)
Legendary hedge-fund manager Luis Stuhlberger continued to take advantage of the volatility brought on by Brazil’s upcoming elections to buy back into the country’s stocks and cut hedges after years of pessimism. Far-right candidate Jair Bolsonaro is seen as the favorite to win as the rejection of the left is showing up sooner than expected, Stuhlberger’s Verde Asset Management SA said in a monthly note to clients.
Insider Buying: Bellerophon Therapeutics Inc (BLPH) Major Shareholder Purchases 200,000 Shares of Stock (XNewsPress.com)
Bellerophon Therapeutics Inc (NASDAQ:BLPH) major shareholder Associates Iv L. P. Venrock purchased 200,000 shares of the firm’s stock in a transaction that occurred on Monday, September 10th. The shares were bought at an average price of $1.22 per share, with a total value of $244,000.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.
Insider Buying: Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Insider Buys 300,000 Shares of Stock (FairFieldCurrent.com)
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) insider Sunil Bhonsle acquired 300,000 shares of the business’s stock in a transaction on Friday, September 21st. The shares were purchased at an average price of $0.25 per share, with a total value of $75,000.00. Following the transaction, the insider now owns 435,578 shares in the company, valued at approximately $108,894.50. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Insider Buying: Spark Energy Inc (SPKE) Director Acquires $1,016,012.80 in Stock (MareaInformativa.com)
Spark Energy Inc (NASDAQ:SPKE) Director W Keith Maxwell III bought 123,904 shares of the business’s stock in a transaction on Friday, September 28th. The shares were acquired at an average price of $8.20 per share, with a total value of $1,016,012.80. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.
Insider Selling: RealPage Inc (RP) CEO Sells 150,000 Shares of Stock (PressOracle.com)
RealPage Inc (NASDAQ:RP) CEO Stephen T. Winn sold 150,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 25th. The shares were sold at an average price of $64.62, for a total value of $9,693,000.00. Following the completion of the sale, the chief executive officer now directly owns 1,086,819 shares of the company’s stock, valued at $70,230,243.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission.
Insider Buying: Odonate Therapeutics Inc (NASDAQ:ODT) CEO Purchases 40,000 Shares of Stock (FairFieldCurrent.com)
Odonate Therapeutics Inc (NASDAQ:ODT) CEO Kevin C. Tang purchased 40,000 shares of the stock in a transaction on Wednesday, September 26th. The shares were purchased at an average cost of $19.75 per share, for a total transaction of $790,000.00. The acquisition was disclosed in a filing with the SEC.
